The primary antibody market will reach $68.27 by 2030 at 8.3% CAGR, driven by biomarker research, rising biotech investment, and advances in antibody engineering and assays.
Read MoreGlobal Central Venous Catheters market size is expected to reach $6.64 billion by 2030 at 9%, segmented as by single-lumen, non-tunneled single-lumen catheters
Read MoreGlobal Central Precocious Puberty market size is expected to reach $3.36 billion by 2030 at 10.1%, segmented as by leuprolide acetate, injectable formulations, depot formulations
Read MorePreventive Healthcare Technologies And Services market size is expected to reach $694.9 billion by 2030 at 15.1%, driven by increasing demand for hospitals.
Read MorePreterm Birth Prevention And Management market size is expected to reach $2.86 billion by 2030 at 7.3%, driven by increasing awareness of maternal and fetal health.
Read MoreGlobal Central Nervous System Lymphoma Treatment market size is expected to reach $1.76 billion by 2030 at 6.6%, impact of pharmaceutical industry growth on advancements in medical treatment
Read MorePressure Ulcers Treatment market size is expected to reach $7.42 billion by 2030 at 5.6%, driven by growing diabetic population.
Read MoreGlobal Central Nervous System Biomarkers market size is expected to reach $9.92 billion by 2030 at 10.2%, the surge in neurological illnesses and the central nervous system biomarker market
Read MoreGlobal Pressure Ulcers market size is expected to reach $5.13 billion by 2030 at 4.7%, rising demand for wound care driving the growth of the market due to increasing chronic wound cases
Read MoreGlobal Central Nervous System (CNS) Lymphoma Market Report 2026–2035: Key Forecasts and Growth Areas
Global Central Nervous System (CNS) Lymphoma market size is expected to reach $2.09 billion by 2030 at 6.4%, the role of mental health issues in shaping the market
Read More